Recent News

There are significant opportunities for long term cost savings that can come from optimizing, simplifying, or removing processing steps. Achieving this will require real-time, actionable data.

Behind the Spec is a series introducing the experienced and diverse team helping bring to life Atonarp's vision of unlocking molecular insights. Meet Optical R&D Director Fahmida Ferdous.

The semiconductor shortage has been well documented. But one emerging issue is generating less attention: the forecasted shortage of certain process gases critical to advanced process control.

Behind the Spec is a series introducing the experienced and diverse team helping bring to life Atonarp's vision of unlocking molecular insights. Meet Franklin Wang, Director of Optical Manufacturing.

How can throughput and yield in semiconductor manufacturing be significantly increased? And not by a few percent, but by as much as 40 to 60 percent for certain machines in one fell swoop?

How can throughput and yield in semiconductor manufacturing be significantly increased? And not by a few percent, but by as much as 40 to 60 percent for certain machines in one fell swoop?

Intel has just said that we’re moving into the "angstrom era." In this new era, we’ll see devices and materials now processed at the atomic level – but what will it take to make this achievable?

Intel has framed its recent R&D roadmap announcements as ushering in the "angstrom era", with devices and materials now processed at the atomic level – but what does this really mean?

Max Maxfield writes for EE Journal, detailing the complexities of semiconductor metrology and the exciting potential of Atonarp's recently-announced Aston platform.

Atonarp has announced Aston, an innovative in-situ semiconductor metrology platform with an integrated plasma ionisation source.

The causes of the chip shortage crisis have been widely discussed, but what about specific solutions?

Atonarp has announced the launch of Aston, an in situ mass spectrometer with an integrated plasma ionisation source for semiconductor metrology.

Atonarp today announced Aston, our advanced metrology platform already helping 3 of the top 5 global fabs increase throughput and yield.

Psi is an intelligent pressure controller developed by ATIK for use with Atonarp’s Aston, a compact mass spectrometer. The combined solution has recently been purchased by Samsung after passing a detailed, multi-month technical feasibility evaluation for an advanced lithography application.The ATIK Psi intelligent pressure controller provides the Atonarp Aston Mass spectrometer with a consistent pressure input, insulating Aston from rapid chamber pressure fluctuations. Atonarp’s Aston affords customers significant benefits via a unique combination of plasma and electron impact ionization sources as well as a self-cleaning capability. These features enable Aston to operate effectively in the most challenging semiconductor process environments.ATIK is performing various analytical and optimization evaluations at Samsung and SK Hynix with the combined Psi and Aston solution, many of which are expected to go to volume production in the coming 12 months.

Prakash Murthy is the co-founder & CEO of Atonarp, a leading molecular diagnostics company HQ in Tokyo Japan. Murthy has two decades of experience in engineering management and entrepreneurial ventures. Murthy also co-founded Inspiration Technologies and C2Silicon Software and served as the CEO of Core Solutions Inc. Murthy has a diverse background in analytical instrumentation, high performance computing, compiler development, networking, and multimedia systems. Murthy has authored 20 patents.Please tell us about Atonarp?Atonarp is leading digital transformation of molecular diagnostics, the company is headquartered in Tokyo Japan, with offices in US and India. We are focused on the two largest markets for molecular diagnostics, namely semiconductor manufacturing and life sciences. We’ve developed highly differentiated products for these two markets.

Atonarp, a manufacturer of molecular sensing and diagnostics products for the semiconductor, industrial, and life sciences industries, today announced it has raised a $50 million Series D financing, l

Founded in 2010, Atonarp produces digital molecular diagnostic solutions for various industries, including pharmaceuticals, semiconductor manufacturing, industrial process control and life sciences.

To deliver point-of-care diagnostics without the need for chemistry sets or finicky reagents, Atonarp has raised $50 million to continue building out its digital, laser-based molecular sensor platform.The Tokyo-based company produces miniaturized and automated mass spectrometers and tools for optical spectroscopy, with plans for tests backed by artificial intelligence that could derive clinical results from very small patient samples.

Atonarp's 'ATON-360' optical spectroscopy platformAtonarp, a Tokyo-based company that sells optics-based molecular sensing equipment, says it has raised $50 million in a series D round of venture funding.The Japanese firm, which also offers miniature mass spectrometers for industrial applications, plans to use the cash to expand operations and advance development of a new platform technology aimed at point-of-care diagnostics and cell biology.

Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp’s Chief Operating Officer.

As the Chief Technology Officer of Flextronics, I started a camera module business which became the world’s largest supplier of embedded cameras with an estimated market share of more than 10%. When w

Banner Industries is pleased to announce that it recently formed a partnership with Atonarp, Inc., effective October 15, 2020. Atonarp, a leading manufacturer of molecular diagnostics products, is spearheading the digital transformation of advanced molecular analysis and quantification in the industrial and healthcare space. Atonarp’s miniature spectrometers capture process-specific data, then translate that data into actionable information.‍Atonarp’s products cater to processes that require advanced molecular analysis for a variety of markets, including pharmaceutical, semiconductor, industrial, and biological applications. Founded in 2010, Atonarp is a relative newcomer to the semiconductor scene, but its innovative, patent-pending technology is already transforming the playing field. Consistently focused on breakthroughs in sensor technology, miniaturization, artificial intelligence, and next-level algorithm and software integration, Atonarp has developed disruptive technology to improve process capabilities, increase chamber throughput, and improve yield in the challenging field of semiconductor manufacturing.

Atonarp, The Molecule Diagnostics Company, is excited to announce that it has been selected as a 2020 TiE50 Winner in the prestigious TiE50 Awards Program. This ten-year-old awards competition is a program of TiEcon, the world's largest conference for tech entrepreneurs. Atonarp was recognized for its innovative molecular diagnostics technology.‍“TiE50 again attracted high potential startups bringing innovation from different parts of the world. Besides the recognition associated with the TiE50 award, this year TiE50 also partnered with Meet the Draper’s, a ground-breaking reality show to give an opportunity to some companies to pitch to the show,” said Kamal Anand, TiE50 Program Chair.

Tokyo-based Atonarp Inc. has a very clear mission, to develop automated, AI-based, miniaturized platforms for mass spectrometry and optical spectroscopy. But that sort of complex molecular analysis has a wide range of potential industry applications, making it difficult to prioritize efforts. The startup company has already commercialized the first quantitative, real-time miniaturized mass spectrometers for semiconductor and pharmaceutical industry gas detection. Its first product is geared toward monitoring pharmaceutical lyophilization, which is a freeze-drying process commonly used by the pharmaceutical industry for product stabilization, for contamination, leaks or other problems.

Financing round brings five new investors to Atonarp, including Japan Post Investment Corporation and SBI Investment Co., Ltd.- Series C was oversubscribed as investor demand was driven by the company's accelerating development progress of disruptive healthcare diagnostics platform.Funding will be used primarily to support Atonarp's product prototyping and commercialization in 2020 and beyond, as well as build on and reinforce the company's technology platforms.TOKYO, Aug. 26, 2019 /PRNewswire/ -- Atonarp, a hi-tech molecular diagnostics company, today announced that it has raised $33 million in an oversubscribed Series C funding round.

Mass Spectrometry has commonly been used in the semi-conductor industry where maintaining a clean environment with minimum contaminants under high vacuum is crucial for successful manufacturing. Since the technology’s early usage for pharmaceutical manufacturing in the 1980 s, particularly in the freeze-drying environment, much has changed. ‍The focus of the current work is aimed at asking some key questions regarding the maturity of the technology, its challenges and importance of having an application-specific instrument for quantitative process analyses applied to freeze-drying. Furthermore, we compare the use of mass spectrometers in early installations from the '80s with recent experiences of the technology in the production and laboratory environments comparing data from different MS technologies.